MENINGOCOCCAL MENINGITIS
Clinical trials for MENINGOCOCCAL MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new MENINGOCOCCAL MENINGITIS trials appear
Sign up with your email to follow new studies for MENINGOCOCCAL MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new vaccine shield adults from four meningitis strains?
Prevention CompletedThis trial is testing an experimental vaccine called Menhycia, designed to protect against four types of meningococcal bacteria (A, C, Y, and W135) that can cause meningitis and bloodstream infections. The study involves about 1,480 healthy adults aged 18 to 55, who will receive …
Matched conditions: MENINGOCOCCAL MENINGITIS
Phase: PHASE3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a new vaccine shield teens from meningitis?
Prevention CompletedThis trial is testing an experimental vaccine designed to protect against four strains of the bacteria that cause meningococcal meningitis, a serious infection of the brain and spinal cord. The study involves around 840 participants aged 7 to 17, who will receive either the new v…
Matched conditions: MENINGOCOCCAL MENINGITIS
Phase: PHASE3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC